A Phase 2/3 interventional study of Tailored behavioral counseling and Tobacco cessation pharmacotherapy in Tobacco Cessation, sponsored by Iowa City Veterans Affairs Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-06.
Sponsored by Iowa City Veterans Affairs Medical Center · Phase 2/3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 190 studies in Tobacco Use Cessation with a site in United States — 30 open to participants now, 41 under way, 2 of them phase 3. Tobacco Use Cessation · United States.
Among the 190 studies in Tobacco Use Cessation with a site in United States, this one is the 124th largest by planned enrollment of the 184 interventional ones that give a count, is one of 9 that started in 2020, is one of 5 in phase 2/3, reaches primary completion later than 0 of the 40 other live ones, and was the 132nd registered.
276 studies on the registry are indexed under Tobacco Use Cessation; 45 are open to participants now.
Browse Tobacco Use Cessation studies →30 of the 190 studies in Tobacco Use Cessation with a site in United States are open now. Recruiting first, the newest first:
University of Pennsylvania · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18–26
University of California, San Francisco · Sites in United States
Ages 18+ · Women only · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 18+
University of Florida · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 23 Tobacco Use Cessation studies recruiting now, 16 (70%) set no upper age limit and 6 (26%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
190 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 20 · Phase 3 23 · Phase 4 14
First in 1984; this study’s year is marked. 9 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 226 across 256 interventional studies indexed under Tobacco Use Cessation.
Median enrollment 213 across the 184 interventional studies, 169 across the 6 observational. Of the 142 that completed or were terminated, 61 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 190 have an industry lead sponsor. The 10 most frequent:
Iowa City Veterans Affairs Medical Center is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
Iowa City Veterans Affairs Medical Center has 1 study filed under Tobacco Use Cessation — fewer than ten, so there is no comparison to draw.
21 of the studies in Tobacco Use Cessation with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06837220University of ChicagoImplementation of Tobacco Cessation Programming at Community Behavioral Health Sites | 2026-12 |
| NCT05445804Johns Hopkins UniversityOral Cannabidiol for Tobacco Cessation | 2026-12-01 |
| NCT07129590University of California, San FranciscoTrauma-Informed Care for Smoking Cessation for Pregnancy | 2026-12-31 |
| NCT05868421VA Office of Research and DevelopmentVeteran Social Support for Enhancing Use of Smoking Cessation Treatment | 2027-02-01 |
| NCT07735286University of PennsylvaniaAutomating Tobacco Cessation in Primary Care | 2027-03-23 |
Add all 21 to your calendar (.ics) → With an account.
Among the 190 studies in Tobacco Use Cessation with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Tobacco use remains prevalent among Veterans. Although effective smoking cessation interventions exist, long-term term quit rates remain sub-optimal. The project will investigate the feasibility of a stepped care approach to treating tobacco use that includes enhancements based on initial response to treatment to augment the investigators' existing tailored tobacco treatment intervention.
Rural tobacco users (cigarette smokers, smokeless tobacco users, and users of other forms of tobacco) from the Iowa City VA Health Care System will be proactively recruited using information obtained from the electronic medical record. All participants will receive the investigators' tailored, six session smoking cessation intervention developed over a series of projects funded by ORH. This includes a counseling protocol tailored to tobacco users' individual needs and associated risk factors as well as pharmacotherapy selected using shared decision making. Participants who are unable to quit initially will be provided with enhanced counseling based on self-monitoring and scheduled reduced smoking. Those who are able to quit using tobacco during the initial treatment phase will be given an extended, four-session counseling protocol that incorporates new content based on established interventions from positive psychology in an effort to reduce relapse.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tailored behavioral counseling combined with tobacco cessation pharmacotherapy.
Behavioral: Tailored behavioral counseling · Drug: Tobacco cessation pharmacotherapy
Participants will initially receive a six-session telephone intervention. Standard cognitive behavioral treatment strategies will be included. Participants will be screened for elevated depressive symptoms, risky alcohol use, and concerns about weight and and offered supplemental behavioral counseling related to these issues as appropriate. Those that are unable to quit tobacco initially will receive an enhanced, four-session counseling module focused on reduced scheduled smoking. Those who do quit tobacco use initially will receive four sessions of extended counseling based on positive psychology intervention strategies.
Pharmacotherapy will be selected based on medical and psychiatric history and potential interactions with other current medications combined with shared decision making. Options will include nicotine gum (2 and 4 mg), nicotine lozenge (2 and 4 mg), nicotine patch (7, 14, and 21 mg), bupropion (150 mg twice daily) and varenicline (1 mg twice daily). Monotherapy and combination therapy options will be provided.
Tobacco cessation
7-day point prevalence tobacco cessation
Time frame: 6 months
Tobacco cessation
7-day point prevalence tobacco cessation
Time frame: 3 months
Salivary cotinine levels (in ng/ml)
Salivary cotinine
Time frame: 6 months
Level of satisfaction with the intervention as measured according to a five-point scale (extremely, very, moderately, slightly, not at all)
Self-reported satisfaction with the intervention according to the dimensions of usefulness, convenience, difficulty, liking, and helpfulness using five response options (extremely, very, moderately, slightly, not at all) using a scale developed specifically for the project.
Time frame: 3 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2020; primary completion for Aug 2021, 11 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Iowa City Veterans Affairs Medical Center